Panoptive
The continuous oversight engine for clinical trials
Founders
- Youssef KallelFounder/CEO
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
MiracleW23Accelerate clinical trials with real-time, actionable insightsShared: biotechActive
DelineateW25Agents for Accelerated Clinical Trial DesignShared: biotechActive
Baseline AIS24AI document creation and data management for clinical trialsShared: biotechInactive
ExcepgenW19Shared: biotechActive
ScoopF25Automating regulatory submissions for life sciencesShared: biotechActive
Also from S25 in AI
Batchmates in Summer 2025.
ConvexiaS25The world's first AI-maximalist pharma companyActive
KERNELS25Crazy fast, open source infra for AI agents to use the InternetActive
LilacS25We sell GPUs.Active
LLM StatsS25Independent AI evaluations labActive
MagnitudeS25Open source inference server for local modelsActive
ManufactS25Cloud infrastructure for MCP servers and Claude / ChatGPT plugins.Active
About Panoptive
We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct. The platform aggregates findings and identifies systemic patterns across sites and subjects before they compound, and tracks every finding through decision, follow-up, and resolution.
San Francisco, CA, USA
Panoptive: questions
Which YC batch was Panoptive in?
Panoptive was in Y Combinator's Summer 2025 batch (S25).
Is Panoptive still active?
Y Combinator lists Panoptive as active.
Who founded Panoptive?
Panoptive's founders, as listed on its YC page: Youssef Kallel (Founder/CEO).
Where is Panoptive based?
Panoptive lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.